WBA After Hours (Walgreens Boots Alliance NASDAQ): $11.98 most active 16 Mar 2026, outlook

WBA stock traded at $11.98 in after-hours trading on 16 Mar 2026 as volume surged to 452,081,061 shares, putting Walgreens Boots Alliance, Inc. (WBA) among the most active names on the NASDAQ. The move comes with the stock sitting near its 50-day average of $11.66 and above its 200-day average of $10.81, while market cap stands at $10.37B in the United States market. We examine price action, valuation, technical signals, and what Meyka AI’s grade and forecast mean for traders and longer-term investors.

Price action and liquidity: WBA stock after hours

WBA stock is trading at $11.98 after hours on NASDAQ with reported volume of 452,081,061, about 26.69x the average daily volume of 16,940,296, indicating heavy retail or block activity. The stock closed from a previous close of $11.92 and sits closer to its 52-week high of $13.25 than the 52-week low of $8.08. High relative volume often precedes short-term volatility, so traders should expect larger intraday swings in USD price.

Fundamentals and valuation: WBA stock metrics

Walgreens Boots Alliance shows mixed fundamentals: trailing EPS is -7.29, giving a negative PE of -1.64, while price-to-book is 1.44 and price-to-sales is 0.09, signaling deep sales coverage relative to market value. The company carries significant leverage with debt-to-equity near 4.04 and current ratio 0.60, which pressures liquidity. Free cash flow per share is -0.59 and book value per share is 8.46, so valuation reflects a turnaround story priced into a low market cap of $10.37B.

Meyka AI grade and forecast: WBA stock rating and target

Meyka AI rates WBA with a score out of 100: 59.53 | Grade: C+ | Suggestion: HOLD. This grade factors S&P 500 and sector comparison, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects a 12-month price target of $14.50, implying an upside of 21.00% versus the current price of $11.98, but forecasts are model-based projections and not guarantees.

Technical setup: WBA stock trading signals

Technically, WBA stock shows a very short-term momentum spike: the 50-day average at $11.66 and 200-day at $10.81 create a bullish short-to-mid setup. On-chain indicators show RSI readings flagged in the data as elevated, suggesting overbought pressure in the immediate session. Traders should watch support near $11.00 and resistance at $13.25, and monitor ATR of 0.16 for expected intraday range in USD.

Catalysts and risks: WBA stock outlook

Key catalysts include upcoming operational updates, international retail performance, and the scheduled earnings announcement on 25 Jun 2025, which could move WBA stock by double-digit percent intraday. Principal risks are high leverage, negative EPS, weak interest coverage at -5.67, and thin current liquidity ratios. Sector trends in Healthcare retail and pharmacy reimbursements will materially influence WBA performance.

Analyst sentiment and news flow: WBA stock updates

Analyst coverage is light and mixed; available consensus signals show limited buys and a single sell, reflecting uncertainty. Recent commentary and deeper company analysis can be found on specialist sites such as Seeking Alpha and MarketBeat for context and idea flow Seeking Alpha analysis and MarketBeat coverage. We mention these sources to show where professional debate is concentrated and to track news that could affect WBA stock.

Final Thoughts

WBA stock is trading at $11.98 in after-hours on NASDAQ with exceptional volume and clear short-term volatility. Fundamentals show a company with strong retail sales but strained margins and leverage, including EPS -7.29, debt-to-equity 4.04, and free cash flow per share -0.59. Meyka AI grades WBA C+ (59.53) | HOLD and projects a 12-month model target of $14.50, implying a 21.00% upside versus the current USD price; this projection is model-based and not a guarantee. For active traders the elevated relative volume and proximity to the 50-day average create trading opportunities. For longer-term investors the key questions are whether Walgreens Boots Alliance can reduce leverage and restore positive EPS. We track upcoming earnings on 25 Jun 2025 and sector reimbursement trends as the primary near-term catalysts that will validate or weaken the Meyka forecast and the current valuation outlook.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.